John Overdeck’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

John Overdeck’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,860	Closed	-$718K	–	3744
2016 Q3	$718K	Buy	+17,860	New	+$441K	﹤0.01%	2210

John Overdeck's CYNA Position: Q4 2016 in Review

John Overdeck sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 17,860 shares — an estimated $718K sold.

John Overdeck first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $718K in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

John Overdeck reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
John Overdeck sold 17,860 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $718K.
John Overdeck first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
John Overdeck's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $718K in Q3 2016.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Two Sigma Investments's 13F filing for Q4 2016, filed 14 Feb 2017.